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Karlsruhe, GermanyABSTRACT The interaction of membranes with peptides and proteins is largely determined by their amphiphilic character.
Hydrophobic moments of helical segments are commonly derived from their two-dimensional helical wheel projections, and
the same is true for b-sheets. However, to the best of our knowledge, there exists no method to describe structures in three
dimensions or molecules with irregular shape. Here, we define the hydrophobic moment of a molecule as a vector in three
dimensions by evaluating the surface distribution of all hydrophilic and lipophilic regions over any given shape. The electrostatic
potential on the molecular surface is calculated based on the atomic point charges. The resulting hydrophobic moment vector is
specific for the instantaneous conformation, and it takes into account all structural characteristics of the molecule, e.g., partial
unfolding, bending, and side-chain torsion angles. Extended all-atom molecular dynamics simulations are then used to calculate
the equilibrium hydrophobic moments for two antimicrobial peptides, gramicidin S and PGLa, under different conditions. We
show that their effective hydrophobic moment vectors reflect the distribution of polar and nonpolar patches on the molecular sur-
face and the calculated electrostatic surface potential. A comparison of simulations in solution and in lipid membranes shows
how the peptides undergo internal conformational rearrangement upon binding to the bilayer surface. A good correlation with
solid-state NMR data indicates that the hydrophobic moment vector can be used to predict the membrane binding geometry
of peptides. This method is available as a web application on http://www.ibg.kit.edu/HM/.INTRODUCTIONUnderstanding the mechanism of interaction between
amphiphilic peptides and membranes is a central goal of
many investigations on antimicrobial agents, cell-pene-
trating carriers, and peripheral membrane proteins in gen-
eral (1–9). For example, membrane binding is the first
step in the formation of peptidic transmembrane pores,
and further transitions between surface-bound and inserted
structures are often of functional significance (10–13). The
structural information of helical membrane-bound peptides
is typically described in an internal coordinate system
defined by the helix tilt angle, azimuthal rotation angle,
and insertion depth, and by whole-body dynamics
(14–18). Structural information is accessible from solid-
state NMR experiments in oriented membrane samples
(19–23) using, for example, 2H-, 15N-, or 19F-NMR
(17,18,24–51). In addition, information about the tilt angle
of a-helices can be obtained by oriented circular dichroism
(29,52–57). In recent years, both coarse-grained and all-
atom molecular dynamics (MD) simulations have been
used to reproduce and predict the geometry of peptide-
membrane assemblies (2,58–62). The use of MD methods
for structure prediction requires analysis tools that condense
large amounts of simulation data into experimentally verifi-
able values.
In this work, we have defined and utilized three-dimen-
sional (3D) hydrophobic moment (HM) vectors as a to ourSubmitted September 9, 2013, and accepted for publication April 7, 2014.
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0006-3495/14/06/2385/10 $2.00knowledge new tool for predicting peptide-bilayer binding
geometries. This 3D approach extends the idea of molecular
hydrophobicity potentials (MHPs), which are based on
heuristic (63) or experimental (64–68) definitions of hydro-
phobicity for whole residues (65), molecular fragments, or
individual atoms (69). Tools like Membrane Protein
Explorer (Stephen White Laboratory, University of Califor-
nia, Irvine, CA) (70) use these hydrophobicity scales to
calculate water-bilayer transfer energies for small peptides.
The first concept of an HM for individual protein helices
was presented in 1982 by Eisenberg et al. (71,72). Based
on their experimentally determined amino acid side-chain
hydrophobicities (72), a two-dimensional (2D) HM vector
is calculated that represents the distribution of hydrophobic
and hydrophilic residues perpendicular to the helix axis. In
this way, it is possible to categorize helical peptides accord-
ing to their amphiphilicity and to roughly predict the geom-
etry of their insertion into a membrane. More recently,
refined hydrophobicity scales have been developed (73),
and that methodology is used regularly for the analysis of
membrane proteins (74). The Eisenberg definition of a 2D
HM vector is useful for a qualitative description of peptide
helices, but it is limited in its applicability to structures of
close-to-ideal a-helical geometry. Amphiphilic gradients
along the helix axis cannot be taken into consideration
either, because the calculation relies on a projection of the
vector onto the plane of the helical wheel. Furthermore,
the commonly used hydrophobicity scales have been deter-
mined with respect to the free energies of transferring iso-
lated amino acid side chains from polar to nonpolarhttp://dx.doi.org/10.1016/j.bpj.2014.04.020
2386 Reißer et al.environments (72). These scales do not take into account the
cooperativity between side chains (e.g., salt bridges), nor
any conformational rearrangements within a whole peptide
(e.g., upon membrane binding).
To establish a simple, and generally applicable, method to
compute 3D HMs for arbitrary molecules, we combine
structural data from MD simulations according to the proto-
col outlined below. It is based on the electrostatic potential
on the peptide surface, computed via Poisson-Boltzmann
continuum electrostatics calculations. We show here, for
two representative peptides of different conformation,
size, and hydrophobicity, that their 3D HM vectors align
with the membrane normal. We have selected a pair of struc-
turally different, well-characterized antimicrobial peptides
(AMPs)—PGLa (11,30,39,41,46,47,51,52,75–79) and the
cyclic b-pleated gramicidin S (48,49,80–82)—as a test set.
For the latter peptide, the currently established methods
for HM calculation are not applicable. Both of these pep-
tides are found to undergo conformational changes upon
membrane binding, so that their HM vectors increase and
their interactions with the lipid bilayer are optimized.METHODS
All MD simulations were conducted using the molecular simulation pack-
age GROMACS 4.5.5 (83). As model systems, we selected two antimicro-
bial peptides: the cyclic decapeptide gramicidin S (GS, charge þ2, cyclo
[PVOL-DF]2, where O stands for ornithine) (48,49,80–82) and the helical
21-mer PGLa (charge þ5, GMASKAGAIAGKIAKVALKAL-NH2)
(11,30,39,41,46,47,51,52,75–78), which we have studied extensively in
the past. Simulations were conducted in methanol or water for solvated
conditions, and in a dimyristoylphosphatidylcholine (DMPC) bilayer for
the membrane-bound states. The water model was TIP3P, and AMBER99
parameters were used for methanol. For the peptide/lipid systems, the
AMBER99SB-ILDN (84) force field was used with the SLIPID force field
for the lipids (85). The starting conformation for gramicidin S was con-
structed using the xleap tool from the AmberTools modeling suite (86),
based on dihedral angles obtained from a high-resolution liquid-state
NMR structure (87). PGLa was modeled as an ideal a-helix, based on
helicity measurements by CD spectroscopy (47). The peptide-membrane
complexes were constructed by conducting unrestrained membrane binding
simulations 10 ns in length, by placing the peptide molecules parallel to
preequilibrated lipid bilayers at distances of 2–4 nm from each other, at
an elevated temperature of 480 K to speed up insertion. During the high-
temperature insertion, hydrogen bonds in PGLa were restrained using dis-
tance restraints of 1000 kJ/(mol nm2) to prevent unfolding. After cooling
down to 303 K, a short equilibration run of 500 ps with position restraints
of 1000 kJ/(mol nm2) on the membrane-inserted peptides was performed to
allow temperature and volume to stabilize. Then, the systems were simu-
lated without any restraints at 303 K for another 650/600 ns (gramicidin
S/PGLa) in the NPT ensemble, until converged structural ensembles were
obtained (see RMSD plots in Figs. S1–S4 in the Supporting Material).
Unrestrained production simulations were conducted using a Nose´-Hoover
thermostat (88) and Parrinello-Rahman barostat (89), with semiisotropic
pressure coupling in the case of lipid bilayer systems. A time step of 2 fs
was used for all simulations, together with the LINCS algorithm (90) to
constrain bonds involving hydrogen atoms. Long-range electrostatics
were treated via particle mesh Ewald combined with a 1.4 nm direct-space
cutoff for van der Waals and Coulomb interactions.
Gramicidin S was simulated for 600 ns at 303 K embedded in a box of
~1000 methanol molecules, and for 650 ns in a lipid bilayer composed ofBiophysical Journal 106(11) 2385–239472 preequilibrated DMPC molecules solvated with ~2000 TIP3P water
molecules and chloride counterions. PGLa was simulated for 600 ns at
303 K in solution in a box with ~6000 water molecules and chloride coun-
terions, and for 600 ns embedded in a preequilibrated bilayer composed of
100 DMPC lipid molecules solvated with ~3000 TIP3P water molecules
and chloride counterions. For each peptide-membrane system, two or three
control simulations were performed, each 400 ns in length and according to
the same protocol, but with slightly different peptide starting positions.
The last 100 ns of each simulation were used to compute and analyze the
HM based on 100 structural snapshots collected at equidistant time steps of
1 ns. In addition, to determine the averaging procedure, we performed the
calculation on one of the PGLa simulations at a smaller time step of 50 ps so
that we would have 20 times more snapshots, and over the last 300 ns
instead of over the last 100 ns. All of these different data sets (100, 2000,
300, and 6000 snapshots) gave almost the same average values for the
HM vector, the maximal difference being 1.2% (see Table S1; also,
Fig. S5 describes the evolution of the different properties). Considering
the fast fluctuations of the values and the considerable amount of calcula-
tion time needed (~1 min/snapshot), we find that a choice of 100 snapshots
taken at time steps of 1 ns for 100 ns of equilibrated trajectory is justified.
Solvent and lipid molecules were removed, and continuum solvent calcu-
lations were set up for the peptides using PARSE radii (91), whereas atomic
partial charges were kept from the force field.
For each structure, the solvent-accessible surface was calculated as a set
of discrete triangles using NanoShaper (92). The APBS (93) numerical
Poisson-Boltzmann solver was used to compute the electrostatic potential,
Ve, on every surface-triangle vertex. The interior dielectric constant for the
peptide solutes was set to 2.0 to account for electronic polarization effects.
Solvent dielectric constants of 78.5 were used for an aqueous environment,
of 32.6 for methanol solvation, and of 20.0 for the membrane-water inter-
face as an interpolation between the polar aqueous and hydrophobic bilayer
interior conditions. Based on the continuum electrostatic calculations, we
define the resulting HM vector, ~m, as
~m ¼
Xn
i¼ 1
X3
j¼ 1

hjVeji  jVejij

 ~rij: (1)
The sum over i runs over all triangles, and the sum over j runs over the three
corner points of each triangle. jVejij is the absolute value of the electric
potential at the corner point labeled ij. All parts of the surface that have
an absolute electric potential, jVej, greater than the average absolute poten-
tial are counted as negative or polar, whereas the parts with lower-than-
average electric potential are counted as positive or unpolar. The average
absolute potential hjVeji is defined as
hjVeji ¼ 1
Atot
Xn
i¼ 1
X3
j¼ 1
jVejij 
Ai
3
: (2)
Due to the uneven spacing of the triangulated surface, the potential on each
vertex is scaled by one-third of the area of the surrounding triangles, Ai. The
whole sum is then divided by the total surface area, Atot. The vector~rij in
Eq. 1 points toward the vertex ij and is defined as
~rij ¼ ~xij  Ai
3  Atot; (3)
where~xij is the actual vertex vector. As above,~xij is scaled by one-third of
the surrounding triangle area. This way, we avoid an overestimation of
highly curved parts of the surface that contain a lot of vertices.
Atot is simply the sum over all triangles:
Atot ¼
Xn
i¼ 1
Ai: (4)
3D Hydrophobic Moment Vectors 2387We use absolute values for the electrostatic potential, since we aim to
describe the differential distribution of polar and unpolar patches on the
surface, effectively constructing a vector, ~m, that points away from the
most polar parts of the molecular surface. By using the difference between
the absolute surface potential at each point and the average absolute surface
potential,~m reflects the distribution of polar patches on the surface (not the
total polarity of the molecule).
If the electrostatic potential is given in kT/e and the vectors in
A˚ngstro¨ms, the resulting HM vector has a unit of 2.56  1012 Vm at
room temperature. Since this unit doesn’t carry any physical implication,
we omit it in the following discussion and give ~m in multiples of kTA˚/e.
For each set of 100 snapshots, we calculated the average HM vector, the
average angular variation from the average vector, and the standard devia-
tion of the vector length. For simulations in the membrane, the angle be-
tween the average HM vector and the membrane normal was calculated
as well. The VMD software (94) was used to visualize the results.RESULTS
Model charge distributions
To illustrate the principle and to help visualize the results
obtained from HM calculations, we created a model system
consisting of a hexagonal pseudomolecule shaped like
benzene, on which we placed varying charge distributions
(Fig. 1). In the initial form, all partial charges were set to
zero, and various sets of 1–4 positive and/or negative
charges, each of magnitude 0.3e, were distributed around
the ring.
The trivial situations of no charge or a single charge result
in no HM or an HM pointing away from the charge, respec-
tively (Fig. 1, A and B). Symmetrical arrangements ofcharges cancel the HM, independent of the sign of these
charges (Fig. 1, C, D, J, and M). Charges of opposite sign
placed closely together (Fig. 1 F) compensate each other’s
effect to some extent, leading to a slightly smaller HM
vector relative to that in the situation with charges of like
sign (Fig. 1 E). HM vectors increase in length the more un-
balanced is the distribution of polar and nonpolar surface
areas (Fig. 1, B, E, and G). The effect of neighboring
charges of opposite sign is described in more detail in
Fig. 1, H and K. In Fig. 1 H, the vector is rotated slightly
relative to that in Fig. 1 G, and in contrast to Fig. 1 J, where
the HM is canceled, a small nonzero vector is found in Fig. 1
K. Reversing the sign of all charges does not influence the
HM at all (compare Fig. 1, I and L, with Fig. 1, H and K,
respectively). Finally, meaningful and comparable HM
vectors can be obtained even in highly charged molecules
of different total molecular charge (Fig. 1, N and O).
These examples show that the HM is a quantity indepen-
dent of the total charge. It is similar in definition to the
dipole moment, but is a different measure of the charge
distribution. The vector represents the distribution of polar
and nonpolar parts of a molecular surface, at the same
time taking into account solvation effects and partial charge
compensation via salt bridges. Since the distribution of
nonpolar surface patches is crucial in many areas of macro-
molecular interactions—from protein oligomerization to
receptor-ligand recognition and peptide-bilayer binding,
the HM vector serves as a useful descriptor of macromolec-
ular shape-dependent properties.FIGURE 1 HM vectors and surface electrostatic
potential for various model charge distributions on
a hexagonal pseudomolecule. The HM vectors
consistently point toward the most nonpolar parts
of the molecular surface, independent of the sign
of the individual charges or the total molecular
charge. The length of the arrow reflects the size
of the HM ( m!¼ 0 in cases without an arrow). To
see this figure in color, go online.
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We calculated the HM based on conformational ensembles
from long MD simulations (several hundred nanoseconds)
for two amphiphilic antimicrobial peptides. The b-pleated
decapeptide gramicidin S (cyclo[PVOL-DF]2) has a
charge of þ2 and possesses an intrinsic C2 symmetry
(48,49,80–82). The a-helical 21-mer PGLa (GMASKAGA
IAGKIAKVALKAL-NH2) has a charge of þ5 due to its
amidated C terminus (11,30,39,41,46,47,51,52,75–79).Gramicidin S in solution
The cyclic antimicrobial peptide gramicidin S was simu-
lated for 600 ns at 303 K, embedded in a cubic box of
~1000 methanol molecules (box side length ~4 nm). The
peptide starting structure was obtained from high-resolution
NMR data (87). All-atom RMSD evolution (see Fig. S1)
shows that a minor structural rearrangement takes place
after 130 ns simulation time, upon which a stable conforma-
tional ensemble is obtained. Fig. 2 gives the representative
structure from a clustering analysis of the peptide, and the
results of HM calculations based on the last 100 ns of the
simulation data.
The HM vector is aligned almost perfectly with the
molecular C2-symmetry axis, as expected, and it points
away from the charged ornithine residues, passing between
the hydrophobic side chains of the four valine and leucine
residues. When all snapshots are aligned, the instantaneous
HM vectors deviate from the time-averaged vector by
11 5 6, and the average length is expressed as 9.3 5
0.9 (mean 5 SD).Gramicidin S in a membrane
Next, we calculated the HM for gramicidin S inserted into a
lipid bilayer (see Fig. 3) for comparison with the results in
isotropic solution (Fig. 2) and to see how the HM vector
aligns with respect to the membrane normal. Here, the snap-
shots were taken from the last 100 ns of a 650 ns simulation
in a bilayer composed of 72 preequilibrated DMPC mole-
cules solvated with ~2000 TIP3P water molecules and chlo-FIGURE 2 (Left) Representative structure of gramicidin S in methanol
with its calculated HM vector. (Right) Electrostatic potential on the sol-
vent-accessible surface of the same structure. The HM vector is pointing
away from the surface region with high electrostatic potential. To see this
figure in color, go online.
Biophysical Journal 106(11) 2385–2394ride counterions. The RMSD evolution after the peptide is
embedded in the membrane shows small conformational
rearrangements up to ~250 ns of simulation time, after
which a stable, converged structure is obtained (see
Fig. S2). The peptide lies directly underneath the zwitter-
ionic lipid headgroups, pointing its charged residues up-
ward, toward the water. The distance between the center
of mass of the heavy backbone atoms (N, Ca, C, and O)
of the peptide and the phosphorus atoms of the monolayer
in which the peptide inserted was calculated from their
average coordinates in the z-direction. To exclude data
where the lipid position is influenced by the peptide, for
each of the 36 lipids, only those time frames in which
the distance to the peptide is >2.5 nm were included in
the calculation. The last 400 ns were used to calculate the
average values, which resulted in ~53,000 data points for
the phosphorus atoms and ~8000 for the peptide. The pep-
tide main chain lies 8.7 A˚ below the average phosphorus
position. The standard deviation for the z-coordinate of
the peptide is 1.4 A˚, whereas the bilayer fluctuates more
strongly, with a standard deviation of 2.2 A˚. All three con-
trol simulations show a very similar average orientation
upon insertion into the membrane. The resulting orientation
of the peptide in the membrane is in full agreement with the
results from solid-state NMR measurements of the C2-sym-
metry axis tilt angle and azimuthal rotation angle in an ori-
ented DMPC sample with a peptide/lipid ratio of 1:80 (49).
The HM vector was calculated using an intermediate
solvent dielectric constant of 20.0 to represent the condi-
tions at the bilayer/water interface region. HM analysis
shows that the fluctuations of the vector in this case are
more pronounced than during the simulation in methanol,
with an average angle variation of 185 10 and a standard
deviation of the absolute length of 52.0 A˚ with respect to
the average HM vector (Fig. 3).
Interestingly, the HM vector has increased significantly,
by >50%, to 15.2 5 2.0. This increase in length is caused
partly by the smaller dielectric constant used in the Pois-
son-Boltzmann calculations (reducing solvent screening),
but also by conformational changes of the peptide upon
membrane binding. Exposing the molecule to a less polar
environment leads to internal rearrangements that result in
a more unequal distribution of polar and nonpolar surface
residues. The charged ornithine side chains now point
directly up into the solvent region, whereas the D-phenylal-
anine rings bend further down toward the hydrophobic
bilayer core. Repeating the calculations of the HM vector
with a dielectric constant of 32.6 yields an average HM
vector length of 11.1, showing that structural rearrange-
ments are responsible for ~30% of the difference in the
HM vector lengths. The remaining 70% difference is due
to the lower dielectric constant and less well screened elec-
trostatic potential on the molecular surface. The resulting
combined forces constrain the surface-bound geometry of
gramicidin S in the membrane and lead to a lengthening
FIGURE 3 (Upper) Representative structure of gramicidin S embedded
in a DMPC membrane (bilayer not shown; aligned horizontally) with its
calculated HM vector. (Lower) Electrostatic potential on the solvent-acces-
sible surface. The HM vector is almost parallel to the membrane normal
(13). To see this figure in color, go online.
3D Hydrophobic Moment Vectors 2389of the HM vector. The angle between the HM vector of the
time-averaged peptide structure and the membrane normal
is small, with a value of only 13, i.e., it points almost
straight into the membrane core, as expected. For individual
snapshots, the angle undergoes considerable fluctuation and
measures on average 29 5 17, indicating that the small,
surface-bound peptide behaves rather dynamically when
embedded in the membrane. We also performed three con-
trol simulations, which gave similar results (see Table S2).FIGURE 4 (Upper) Representative structure of PGLa in a DMPC
membrane (bilayer not shown; aligned horizontally) with its calculated
HM vector. (Lower) Electrostatic potential on the solvent-accessible sur-
face. To see this figure in color, go online.PGLa in a membrane
For peptides that retain a predominantly helical structure in
their membrane-bound state, we can compare the 3D HM
vector defined above with the conventional 2D HM. The
antimicrobial peptide PGLa, which contains five positively
charged residues along one face of the a-helix, was simu-
lated for 600 ns at 303 K, embedded in a preequilibrated
bilayer composed of 100 DMPC lipid molecules, solvated
with ~3000 TIP3P water molecules and chloride counter-
ions. The RMSD evolution of the surface-bound peptide
shows a stable structure with no significant conformational
changes after 200 ns simulation time (see Fig. S3). PGLa
maintains a completely helical fold in the unrestrained
simulation, in good agreement with the high helical content
measured in CD experiments (47). The helix lies stably in
the membrane-water interface. The insertion depth of the
peptide was calculated as outlined in the previous section.
For the linear PGLa molecule, we used average positionsof the centers of mass of the heavy backbone atoms (N,
Ca, C, and O) for the C- and N-terminal residues and those
of the 50 lipids that are>2.5 nm away from the peptide. The
C terminus lies 10.8 A˚ below and the N-terminus only 5.3 A˚
below the average phosphorus layer. The standard devia-
tions for the z-coordinates are 2.0 A˚ for the N terminus
and 2.7 A˚ for the C terminus of PGLa, and 2.4 A˚ for the
phosphorus atoms. All control simulations show a very
similar average orientation upon insertion into the mem-
brane. The peptide is pointing its charged lysine side chains
up toward the water phase. The long axis is aligned flat on
the membrane surface at an average tilt angle of 93 5 7
with respect to the membrane normal. This alignment is
very close to the experimentally obtained 95 determined
by solid-state NMR in oriented DMPC bilayers at a pep-
tide/lipid molar ratio of 1:200 (30,47,77,79).
The HM vector analysis was conducted over the last
100 ns of simulation time. The resulting HM vector and
the corresponding electrostatic surface potential of the
molecule are shown in Fig. 4.
The HM vector points away from the charged lysine
residues, but the angle between the HM vector and the helix
axis is only 39 5 5. This makes an important difference
compared to the implicit value of 90 imposed by the
conventional 2D HM analysis. Several factors contribute
to the pronounced inclination of the vector toward the C ter-
minus, including an unbalanced charge distribution along
the peptide sequence, the additional charge at the uncapped
N-terminus, and a large hydrophobic patch formed by aBiophysical Journal 106(11) 2385–2394
2390 Reißer et al.C-terminal leucine residue. At the same time, the HM vector
of the time-averaged peptide structure is tilted quite far
from the membrane normal, by 53. When this angle is
added to its tilt angle of 39 relative to the helix axis, the
sum of 92 is consistent with a peptide helix aligned essen-
tially perpendicular to the membrane normal, as described
above and by solid-state NMR. The HM projection perpen-
dicular to the helical axis aligns well with the membrane
normal. The length of the vector is 44.95 3.3, significantly
larger than the value for gramicidin S, above, which
indicates that PGLa is not only highly charged but has a
very unequal polarity distribution along the helix. We also
performed two control simulations, which gave very similar
results (Table S2).
A comparison of the 3D HM vector obtained by our
method with the original 2D HM definition by Eisenberg
et al. (72) shows that the projection of the 3D HM vector
onto the plane orthogonal to the helix axis results in closely
aligned vectors (within an angle of 18; see Fig. 5).
Notably, the new definition of the HM in 3D not only
properly reproduces the unequal distribution of polar resi-
dues on the helical wheel of PGLa but also contains addi-
tional information about their distribution along the helix.
Our HM calculations suggest that PGLa should have a ten-
dency to insert its C terminus more deeply into the hydro-
phobic core than its N-terminus, such that the HM aligns
more closely with the membrane normal. Such a strongly
tilted peptide orientation is not seen in our simulations,
probably due to sampling constraints. The membrane-bound
geometry observed here corresponds to the so-called surface
state obtained by solid-state NMR at a peptide/lipid ratio of
1:200 (30,47,77,79). However, a second, distinct mem-
brane-bound structure has been found for PGLa in NMR
experiments at a higher peptide/lipid ratio of 1:50
(30,47,77,79). In this so-called tilted state, the helix axisFIGURE 5 (Left) Projection of the 3D HM vector from this work onto the
helix cross section of PGLa. (Right) Conventional 2D HM vector calculated
according to Eisenberg (71). (The vectors have been normalized.) To see
this figure in color, go online.
Biophysical Journal 106(11) 2385–2394is inclined at an angle of 127 with respect to the membrane
normal. In this tilted orientation, our HM vector would be
aligned almost parallel to the membrane normal (at 17,
as seen in Fig. 6).
It has been argued, based on the concentration depen-
dence (47,77), and on MD analysis (1,62), that the tilted
state of PGLa may be accompanied by dimerization. The
peptide obviously experiences different forces and different
stabilizing interactions under different conditions, and it
will adjust its geometry in the membrane according to the
dominant influence. We may thus suggest that the HM
vector represents one of these factors and contributes
strongly to stabilizing the strongly tilted membrane-bound
structure of PGLa that has been observed experimentally.PGLa in water
We showed above that for gramicidin S, the HM vector
becomes longer when the peptide binds to a membrane.
To check whether this holds also for PGLa, starting from
an ideal helical structure, the peptide was simulated for
600 ns in a water box that included counterions. However,
the peptide quickly unfolded in the polar medium and
collapsed into a compact state resembling an unstructured
coil (see RMSD plot in Fig. S4). Here, the polar regions
tend to point toward the surrounding solvent, whereas the
hydrophobic residues are packed into the core. The HM
vector is drastically reduced in this conformation, by
~90%, to an average length of 5.55 1.2 (see Fig. 7).
The HM calculation was performed both with a dielec-
tric constant of 78.5 to represent water, and with a dielec-
tric constant of 20.0, as above, to be able to distinguishFIGURE 6 (Left) Tilted state of PGLa as measured experimentally by
solid-state NMR in DMPC membranes at a peptide/lipid ratio of 1:50
(79) (bilayer not shown; aligned horizontally), shown with its HM vector
calculated from MD simulations. (Right) Electrostatic potential on the
solvent-accessible surface. To see this figure in color, go online.
FIGURE 7 (Left) Representative structure of largely unfolded PGLa in
water with its calculated HM vector. (Right) Electrostatic potential on the
solvent-accessible surface. To see this figure in color, go online.
3D Hydrophobic Moment Vectors 2391between the contribution of the different dielectric environ-
ment and that of the conformational change. We find that
around two-thirds of the reduction of the HM can be attrib-
uted to the conformational change and one-third to the
different dielectric constant used in the electrostatics
calculations.Results summary
The HM vector properties for the different systems investi-
gated here are summarized in Table 1. We see that the time-
dependent HM vector typically maintains a fairly constant
length and orientation with respect to the peptide structure
during any given simulation, but it can undergo considerable
changes when the environmental conditions change, e.g.,
upon membrane embedding. The HM indicates a favorable
orientation in which a peptide can bind to a lipid bilayer
surface. However, the HM vector does not have to be
aligned parallel with the membrane normal if the peptide
in question contains an asymmetrical distribution of charged
or nonpolar residues along its sequence, or if other forces
dominate the geometry of peptide insertion.TABLE 1 Summary of the HM vectors calculated for the last 100 ns
System
Average HM vector
length (kTA˚/e)a
Average angle deviation
from average HM vector (
Gramicidin S in methanol 9.3 5 0.9 11.15 5.9
Gramicidin S in membrane 15.25 2.0 17.95 9.5
PGLa in water 5.5 5 1.2 21.15 13.0
PGLa in membrane 44.95 3.3 5.75 2.8
Values are expressed as the mean5 SD.
aAverage of the absolute values of all 100 vectors calculated from the snapshot
bAverage angular difference between each snapshot vector and the average vect
tively high standard deviations relative to these values show that the single-fram
would have to be very small) but rather are spread.
cAverage of the angle between the HM vector and the membrane normal in eac
dAngle between the average HM vector after all snapshots are aligned, and the m
in column 4. This shows that for the symmetrical gramicidin S, the HM vector is
values.DISCUSSION
The 3DHM vector as described in this work extends the clas-
sical 2DHMconcept introduced byEisenberg and co-workers
in several ways. 1), It is applicable to arbitrary molecular
structures, not only to regular conformations like a-helices
or b-sheets. Individual side-chain rearrangements are taken
into account as well as bent helices, partial unfolding, or un-
usual structures like the cyclic gramicidin S. 2), Charge
compensation caused by salt bridges or hydrogenbond forma-
tion is reflected in the resulting electrostatic potential on the
molecular surface. 3), In addition, it is possible to perform
MD simulations to calculate the HM time average over a real-
istic ensemble of highly dynamical peptide structures in fluid
membranes.
The results obtained for the HM vectors of gramicidin S
in solution and when bound to a DMPC bilayer agree very
well with both chemical intuition and experimental data.
We find that the peptide rearranges its flexible side chains,
resulting in an elongated HM vector in the membrane-bound
state. For PGLa, the HM vector points into the membrane at
an oblique angle in our simulations, due to the uneven
arrangement of polar residues along the helix. Interestingly,
the HM vector does not align with the membrane normal in
this simulated orientation, but it would do so in another
tilted alignment that has been experimentally observed at
a different peptide/lipid ratio. We find that PGLa is not
stable as a helix in aqueous solution, but it forms an amphi-
philic helix upon binding to the membrane surface, in full
agreement with experimental observations (47,96). This
structural rearrangement produces a long HM vector only
for the membrane-bound state.
The 3D HM vector is a useful tool for classifying the
amphipathicity of peptides. It can predict which face of
the peptide orients toward the membrane, even though it
may not be sufficient to explain the exact alignment of the
membrane-inserted monomer. There are several forces,
and possibly competing contributions, that will determine
the actual orientation of a peptide bound to a lipid bilayer.of long MD simulations
)b
Average angle between HM
vector and membrane normal ()c
Angle between average HM
vector and membrane normal ()d
— —
28.85 17.1 12.6
— —
53.35 6.6 53.2
s.
or when all snapshot conformations have been optimally aligned. The rela-
e vectors are not on a cone around the average vector (in which case they
h snapshot.
embrane normal. For gramicidin S, it is remarkably different from the value
very flexible and averaging significantly decreases the single-frame angular
Biophysical Journal 106(11) 2385–2394
2392 Reißer et al.Regarding the HM vector, we expect that it has a stronger
effect on shorter, and thus more globular, peptides (like
gramicidin S) than on extended structures (like PGLa).
Other, specific interactions between the lipid headgroups
and peptide side chains, such as hydrogen bonds, could
play a role in preventing the peptide from taking on a posi-
tion in which the HM vector would be perfectly aligned with
the membrane normal. Also, the overall dipole moment of
the peptide (e.g., as intrinsically found along every helix
axis) is of importance in determining the preferred geometry
of insertion into charged as well as zwitterionic membranes.
Furthermore, the spontaneous lipid curvature and bilayer
thickness have been shown to have an effect on the orienta-
tion of inserted peptides (27,28,97–99).SUPPORTING MATERIAL
Five figures and two tables are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(14)00405-6.REFERENCES
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